These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35052486)

  • 1. Gene Network of Susceptibility to Atypical Femoral Fractures Related to Bisphosphonate Treatment.
    Garcia-Giralt N; Roca-Ayats N; Abril JF; Martinez-Gil N; Ovejero D; Castañeda S; Nogues X; Grinberg D; Balcells S; Rabionet R
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.
    Koh JH; Myong JP; Yoo J; Lim YW; Lee J; Kwok SK; Park SH; Ju JH
    Osteoporos Int; 2017 Nov; 28(11):3251-3259. PubMed ID: 28748389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risk factors, and fracture healing of atypical femoral fractures: a multicenter case-control study.
    Lim SJ; Yeo I; Yoon PW; Yoo JJ; Rhyu KH; Han SB; Lee WS; Song JH; Min BW; Park YS
    Osteoporos Int; 2018 Nov; 29(11):2427-2435. PubMed ID: 30039251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.
    Qiu S; Dhaliwal R; Divine G; Warner E; Rao SD
    J Bone Miner Res; 2024 May; 39(4):417-424. PubMed ID: 38477744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Characterization of a GGPPS Variant Identified in Atypical Femoral Fracture Patients and Delineation of the Role of GGPPS in Bone-Relevant Cell Types.
    Roca-Ayats N; Ng PY; Garcia-Giralt N; Falcó-Mascaró M; Cozar M; Abril JF; Quesada Gómez JM; Prieto-Alhambra D; Nogués X; Dunford JE; Russell RG; Baron R; Grinberg D; Balcells S; Díez-Pérez A
    J Bone Miner Res; 2018 Dec; 33(12):2091-2098. PubMed ID: 30184270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone cross-sectional geometry is not associated with atypical femoral fractures in Asian female chronic bisphosphonate users.
    Chou AC; Ng AC; Png MA; Chua DT; Ng DC; Howe TS; Koh JS
    Bone; 2015 Oct; 79():170-5. PubMed ID: 26067179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for development of atypical femoral fractures in patients on long-term oral bisphosphonate therapy.
    Franceschetti P; Bondanelli M; Caruso G; Ambrosio MR; Lorusso V; Zatelli MC; Massari L; Degli Uberti EC
    Bone; 2013 Oct; 56(2):426-31. PubMed ID: 23871850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fractures.
    Zhou W; Ås J; Shore-Lorenti C; Nguyen HH; van de Laarschot DM; Sztal-Mazer S; Grill V; Girgis CM; Stricker BHC; van der Eerden BCJ; Thakker RV; Appelman-Dijkstra NM; Wadelius M; Clifton-Bligh RJ; Hallberg P; Verkerk AJMH; van Rooij JGJ; Ebeling PR; Zillikens MC
    J Bone Miner Res; 2024 Sep; 39(9):1315-1326. PubMed ID: 39126371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures.
    Garcia-Giralt N; Ovejero D; Grinberg D; Nogues X; Castañeda S; Balcells S; Rabionet R
    Hum Genomics; 2024 Aug; 18(1):87. PubMed ID: 39148098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High bisphosphonate treatment rates and the prevalence of atypical femoral fractures in patients with systematic lupus erythematosus: a single-center retrospective study performed in Japan.
    Sato H; Kondo N; Wakamatsu A; Kobayashi D; Nakatsue T; Wada Y; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
    Rheumatol Int; 2019 Oct; 39(10):1803-1810. PubMed ID: 31385078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur.
    Zanchetta MB; Diehl M; Buttazzoni M; Galich A; Silveira F; Bogado CE; Zanchetta JR
    J Bone Miner Res; 2014 Apr; 29(4):999-1004. PubMed ID: 24115250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Contribution of Deleterious Rare Alleles in ENPP1 and Osteomalacia Causative Genes to Atypical Femoral Fracture.
    Furukawa H; Oka S; Kondo N; Nakagawa Y; Shiota N; Kumagai K; Ando K; Takeshita T; Oda T; Takahashi Y; Izawa K; Iwasaki Y; Hasegawa K; Arino H; Minamizaki T; Yoshikawa N; Takata S; Yoshihara Y; Tohma S
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1890-e1898. PubMed ID: 35038731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical femur fracture during bisphosphonate drug holiday: a case series.
    Lovy AJ; Koehler SM; Keswani A; Joseph D; Hasija R; Ghillani R
    Osteoporos Int; 2015 Jun; 26(6):1755-8. PubMed ID: 25832177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate treatment and the risk of atypical femoral fracture among patients participating in a Fracture Liaison Service of a tertiary medical center.
    Bareli N; Gat R; Makarov V; Siris E; Fraenkel M; Yoel U
    Arch Osteoporos; 2021 Jun; 16(1):86. PubMed ID: 34089098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and associated factor of atypical periprosthetic femoral fracture after hip arthroplasty.
    Lee YK; Park CH; Kim KC; Hong SH; Ha YC; Koo KH
    Injury; 2018 Dec; 49(12):2264-2268. PubMed ID: 30245278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Genetics of Atypical Femur Fractures-a Systematic Review.
    Zhou W; van Rooij JGJ; Ebeling PR; Verkerk AJMH; Zillikens MC
    Curr Osteoporos Rep; 2021 Apr; 19(2):123-130. PubMed ID: 33587247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.
    Sato H; Kondo N; Wada Y; Nakatsue T; Iguchi S; Fujisawa J; Kazama JJ; Kuroda T; Nakano M; Endo N; Narita I
    Osteoporos Int; 2016 Mar; 27(3):1217-1225. PubMed ID: 26519417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Genome-Wide Association Study of Bisphosphonate-Associated Atypical Femoral Fracture.
    Kharazmi M; Michaëlsson K; Schilcher J; Eriksson N; Melhus H; Wadelius M; Hallberg P
    Calcif Tissue Int; 2019 Jul; 105(1):51-67. PubMed ID: 31006051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
    Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
    J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.